1. Management of Systematic Lupus Erythematosus

3. Case 1 New-Onset Arthritic Flare

4. Initial Assessment in Primary Care

5. Medication Nonadherence in SLE

6. Therapeutic Drug Monitoring to Measure Nonadherence

7. Identifying Patients at Increased Risk for Flare and Persistently Active Disease

8. Laboratory Assessments in Patients With SLE

9. Measuring Disease Activity in the Clinic

10. Initial Approach Increase Steroid Dose

11. Maximizing Benefit From Steroid Use

12. HCQ Use in SLE

13. Case 1 Follow-up in Primary Care

14. Nonbiologic Immunosuppressive Therapy

15. Belimumab Efficacy

16. Belimumab Safety

17. Considerations for Treatment Selection and Monitoring

18. Additional Considerations for Women of Childbearing Age

19. Case 2 Recognizing Complications of SLE

20. Case 2 Management Considerations

21. Case 3 Concerns About Steroid Side Effects

22. Quantifying Adverse Effects of Steroid Use

23. Approaches to Minimize Risks of Steroid Use

24. Importance of Engaging the Patient in the SLE Management Plan

25. Looking Ahead Ongoing Challenges in the Management of SLE

26. Abbreviations

27. Abbreviations (cont)